Chemical formula: C₂₇H₂₉NO₁₀ Molecular mass: 527.52 g/mol PubChem compound: 30323
Daunorubicin is indicated for:
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)
As an antimitotic and cytotoxic for the induction of remissions in acute lymphocytic and myelogenous leukaemias.
Daunorubicin, as part of combination regimen, is indicated for the treatment of acute lymphocytic leukemia and acute myeloid leukemia in children.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Daunorubicin is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
